{"schema_version":"1.0","hypothesis_id":9407,"triple":{"drug":"afatinib","drug_canonical":"afatinib","mediator":"EGFR","mediator_canonical":"EGFR","outcome":"glioblastoma","outcome_canonical":"glioblastoma"},"domain":{"domain":"cross_domain","source":"pancreatic_cancer","target":"glioblastoma"},"provenance_completeness":"partial_backfill","completeness_notes":"Backfilled retroactively from DB state on 2026-05-13. The pipeline_run this row references was created by the backfill script, not by the actual generation orchestrator. Source papers, claims, scoring, and embedding config are recovered; generation-time metadata (exact git commit at gen time, host, exact command) is not recoverable.","source_papers":[{"doi":"10.3389/fonc.2025.1713181","pmid":"41473440","year":2025,"roles":["mediator_outcome"],"title":"A PET-CT study of the uptake of labeled aptamers [18F]FB-Gol1 and [18F]FB-GR20 in rat 101.8 glioblastoma model","journal":"Front Oncol","work_id":110769,"publication_date":"2025-12-15"},{"doi":"10.1016/j.neo.2024.101070","pmid":"39541736","year":2024,"roles":["drug_mediator"],"title":"A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR","journal":"Neoplasia","work_id":173488,"publication_date":"2024-11-14"},{"doi":"10.3390/ijms25042316","pmid":"38396993","year":2024,"roles":["mediator_outcome"],"title":"Epidermal Growth Factor Receptor Inhibitors in Glioblastoma: Current Status and Future Possibilities","journal":"Int J Mol Sci","work_id":570,"publication_date":"2024-02-15"},{"doi":"10.3892/or.2020.7822","pmid":"33125153","year":2020,"roles":["drug_mediator"],"title":"Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer","journal":"Oncol Rep","work_id":176730,"publication_date":"2020-10-22"}],"source_paper_count":4,"extracted_claims":[{"side":"drug_mediator","object":"EGFR","context":"in patient-derived pancreatic ductal adenocarcinoma cells","subject":"afatinib","work_id":173488,"claim_id":126062,"polarity":"positive","predicate":"inhibits","confidence":1.0,"extraction_run_id":23},{"side":"drug_mediator","object":"EGFR","context":"in HPCCLs","subject":"afatinib","work_id":176730,"claim_id":132426,"polarity":"positive","predicate":"inhibits","confidence":0.9,"extraction_run_id":23},{"side":"mediator_outcome","object":"glioblastoma","context":"in over 50% of glioblastoma cases","subject":"EGFR","work_id":570,"claim_id":1131,"polarity":"positive","predicate":"associated_with","confidence":0.95,"extraction_run_id":7},{"side":"mediator_outcome","object":"glioblastoma","context":"rat 101.8 glioblastoma model","subject":"EGFR","work_id":110769,"claim_id":85806,"polarity":"positive","predicate":"associated_with","confidence":0.9,"extraction_run_id":19}],"extracted_claim_count":4,"extraction":{"model":"deepseek-v4-flash","model_source":"configured","prompt_version":"v1_2026_05_07","run_ids":[7,19,23]},"bridge":{"a_to_b_predicate":"inhibits","b_to_c_predicate":"associated_with","a_to_b_evidence_count":2,"b_to_c_evidence_count":2,"edge_support_log_ab":1.0986122886681098,"edge_support_log_bc":1.0986122886681098,"novelty_factor":1.0,"direct_a_to_c_count":0},"embedding":{"model":"bge-m3","dim":1024,"max_length":8192,"similarity_scores":{}},"scoring":{"method":"swanson_abc_log_evidence_with_novelty_penalty","formula":"score = min((log(ab+1) + log(bc+1)) * novelty / 10, 1.0); novelty = 1.0 if direct==0 else 0.7 / (direct+1)","score_raw":0.21972245773362195,"score":0.21972245773362195,"quality_tier":"mid","quality_reason":null},"pipeline_run":{"id":4,"run_uuid":"eb8b7730-d92e-4cd5-95dd-95f6c5d62cc2","command":"scripts/backfill_provenance_v2.py:v2_2026_05_12","status":"completed","git_commit":"9996ffaa56e9b7cd5f677bd8203624c2c18aa000","host":"MacBook-Pro-Daniel96.local","started_at":"2026-05-12T21:35:53.363326+00:00","ended_at":"2026-05-12T21:43:41.903387+00:00","notes":"Retroactive provenance backfill on 2026-05-13 for snapshot v2_2026_05_12. Synthetic pipeline_runs row — original generation run records are lost (pre-date provenance schema). All recoverable fields populated from current DB state (claims, works, repurposing_hypotheses); pipeline_run record is synthetic, hence completeness='partial_backfill'.\nBackfilled 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.\nRefreshed 1,618 provenance rows. Source papers: avg=3.73, zero=0. Claims matched: avg=4.09, zero=0.","domains":["als","alzheimer","depression","epilepsy","glioblastoma","inflammatory_bowel_disease","multiple_sclerosis","pancreatic_cancer","rheumatoid_arthritis","type_2_diabetes"]},"generated_at":"2026-05-12T21:43:40.211207+00:00"}